tirzepatide and osa In the two SURMOUNT-OSA trials, researchers assessed the efficacy safety of for the treatment of adults with obstructive sleep apnea and obesity. Full results of both trials and Plain Language Weight-loss drug Zepbound resolves sleep

Tirzepatide Outcomes (SURMOUNT-1) The SURMOUNT-1 randomized clinical trial evaluated tirzepatide at three dose levels: 5 mg, 10 mg, and 15 mg weekly in adults with obesity

Zofran is FDA-approved to treat and prevent nausea from surgery, chemotherapy, and radiation, but it's commonly prescribed off-label to treat all types of nausea

This fatigue usually improves after the first month, but some patients experience ongoing low energy throughout treatment

(Germany) Hanmi Pharmaceutical Co., Ltd

If you continue to feel drained or notice that fatigue interferes with daily activities, its a good idea to check with a healthcare provider